A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
Clinical trial NCT04595162 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04595162
- Sponsor
- Peking University Third Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2023-12-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.